Kaleyra
KLR

From March 31,2023 to June 30, 2023 Stock-based compensation (RSUs)

From December 31, 2022 to March 31, 2023 Stock-based compensation (RSUs)

Kaleyra, Inc. today announced that the Company’s Board of Directors has approved a 1-for-3.5 reverse stock split of the Company’s issued and outstanding common stock.

From June 30, 2022 to September 30, 2022 Stock-based compensation (RSUs)

From March 31, 2022 to June 30, 2022 Stock-based compensation (RSUs)

From December 31, 2021 to March 31, 2022 Stock-based compensation (RSUs)

From December 31, 2020 to December 31, 2021 Conversion of Cowen Note Forfeiture of 2020 Sponsors' Earnout Shares Stock-based compensation (RSUs) Warrants exercised for common stock Proceeds from issuance of common stock in Private Investment in Public Equity offering, net of issuance costs Common stock issued to Vivial equity holders (mGage acquisition)

From June 30, 2021 to September 30, 2021 Stock-based compensation (RSUs)

From March 31, 2021 to June 30, 2021 Stock-based compensation (RSUs) Proceeds from issuance of common stock in Private Investment in Public Equity offering, net of issuance costs Common stock issued to Vivial equity holders (mGage acquisition)

From December 31, 2020 To March 31, 2021 Conversion of Cowen Note Forfeiture of 2020 Sponsors' Earnout Shares Stock-based compensation (RSUs) Warrants exercised for common stock

From December 31, 2019 to December 31, 2020 Common stock repurchased in connection with forward share purchase agreements Warrants exchange for Common Stock Stock-based compensation (RSUs) Proceeds from issuance of common stock in public offering, net of issuance costs Common stock issued to sellers (Earn-out 2019) Common stock issued to settle a payable

From June 30, 2020 to August 3, 2020 Common stock repurchased in connection with forward share purchase agreements Stock-based compensation (RSUs) Proceeds from issuance of common stock in public offering, net of issuance costs

from March 31, 2020 to June 30, 2020 Common stock repurchased in connection with forward share purchase agreements Stock-based compensation (RSUs) Proceeds from issuance of common stock in public offering, net of issuance costs Common stock issued to sellers (Earn-out 2019) Common stock issued to settle a payable

1.Common stock offered by the company 7,777,778 shares 2.The number of shares of common stock to be outstanding after this offering is based on 20,221,935 shares of common stock outstanding as of May 31, 2020

From December 31, 2019 to March 31, 2020 Common stock repurchased in connection with forward share purchase agreements Stock-based compensation (RSUs) Common stock issued to settle a payable

From December 31, 2018 to December 31, 2019 Business Combination

Following the approval of the proposals by the Company’s stockholders, on November 25, 2019, the parties to the Stock Purchase Agreement consummated the Business Combination. At the Closing on November 25, 2019, the Company issued the Notes to each of Esse Effe and Maya in the amount of $6,000,000 and $1,500,000, respectively, and also issued the Cash Consideration Notes to each of Esse Effe and Maya in the identical respective amounts. Also at the Closing, the Company issued on November 25, 2019, 10,687,106 shares of common stock to the holders of capital stock of Kaleyra S.p.A. Prior to the Special Meeting, holders of 3,668,303 public shares of the Company’s common stock exercised their right to redeem those public shares for cash at a price of $10.5019 per share, for an aggregate of approximately $38.5 million. Immediately after giving effect to the Business Combination (including as a result of the redemptions described above, and the automatic conversion of rights into shares of common stock), there were 19,977,101 shares of the Company’s issued and outstanding common stock.

From October 1, 2018 to June 30, 2019 Redemption of public shares Shares subject to redemption

From October 9, 2017 to September 30, 2018 Sale of common stock to Founders at $0.005858 per share Sale of common stock to Founders in private placement at $10 per share Forfeiture or cancellation of shares Issuance of Insider shares for no consideration Sale of common stock in Initial Public Offering Sale of common stock in Over-Allotment Option Shares subject to redemption